Recruiting A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions NCT06308419 Conditions Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Recruiting CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. NCT02789384 Conditions Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more Locations Institut Bergonié — Bordeaux, France Centre Georges François Leclerc — Dijon, France Centre Oscar Lambret — Lille, France Centre Léon Bérard — Lyon, France View more locations Show fewer locations Loading locations... View Trial Details
Completed Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide NCT02805725 Conditions Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more Locations Institut Bergonié — Bordeaux, France View Trial Details
Completed Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE NCT06535997 Conditions Adenocarcinoma, Angiosarcomas, Cancer, +29 more Locations Centre François Baclesse, Centre de lutte contre le cancer (CLCC) — Caen, France Hôpital Michallon, CHU de Grenoble-Alpes — Grenoble, France View Trial Details
